KRAS and pancreatic neoplasm: It is especially remarkable that significant and specific knockdown of the KRAS G12D allele, with no influence on the wild-type allele, in pancreatic cancer cells was accomplished and inhibited tumor growth in vitro and in xenograft mouse models (52).